As a new finding, we also documented significantly higher levels of blood p-tau 217 in ALS, but to a lesser extent than in AD, a result that well supports the higher accuracy of p-tau 217 for AD pathology compared to p-tau 181, as previously described5,7. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.